ERBB2 c.3629C>A ;(p.P1210H)

Variant ID: 17-37884158-C-A

NM_004448.2(ERBB2):c.3629C>A;(p.P1210H)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer.

Frontiers In Oncology
Wang, Zhenghang Z; Liu, Chang C; Bai, Yuezong Y; Zhao, Xiaochen X; Cui, Longgang L; Peng, Zhi Z; Zhang, Xiaotian X; Wang, Xicheng X; Zhao, Zhengyi Z; Li, Jian J; Shen, Lin L
Publication Date: 2021

Variant appearance in text: ERBB2: 3629C>A; P1210H
PubMed Link: 34858840
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page